Vivakor
VIVK
#10250
Rank
C$20.08 M
Marketcap
C$0.12
Share price
-11.60%
Change (1 day)
-93.91%
Change (1 year)

P/E ratio for Vivakor (VIVK)

P/E ratio as of December 2025 (TTM): -0.1281

According to Vivakor's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.128116. At the end of 2023 the company had a P/E ratio of -1.81.

P/E ratio history for Vivakor from 2009 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2023-1.81121.8%
2022-0.8144-95.7%
2021-18.9-66.66%
2020-56.8
2009-4.11

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Merrimack Pharmaceuticals
MACK
-138 107,259.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-19.0 14,712.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-17.9 13,838.23%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.